666 related articles for article (PubMed ID: 19272313)
1. CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases.
Klinman DM; Klaschik S; Sato T; Tross D
Adv Drug Deliv Rev; 2009 Mar; 61(3):248-55. PubMed ID: 19272313
[TBL] [Abstract][Full Text] [Related]
2. Use of CpG oligodeoxynucleotides as immune adjuvants.
Klinman DM; Currie D; Gursel I; Verthelyi D
Immunol Rev; 2004 Jun; 199():201-16. PubMed ID: 15233736
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant activity of CpG oligodeoxynucleotides.
Klinman DM
Int Rev Immunol; 2006; 25(3-4):135-54. PubMed ID: 16818369
[TBL] [Abstract][Full Text] [Related]
4. Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides.
Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA
Adv Drug Deliv Rev; 2009 Mar; 61(3):226-32. PubMed ID: 19162103
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant properties of CpG oligonucleotides in primates.
Verthelyi D
Methods Mol Med; 2006; 127():139-58. PubMed ID: 16988453
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation of Japanese encephalitis vaccine through CpG oligodeoxynucleotides in mice.
Sidhapuriwala JN; Sivalingam SP; Lu J; Moochhala SM
Scand J Immunol; 2006 Oct; 64(4):370-5. PubMed ID: 16970676
[TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo.
Zhang L; Tian X; Zhou F
Int Immunopharmacol; 2007 Dec; 7(13):1732-40. PubMed ID: 17996683
[TBL] [Abstract][Full Text] [Related]
8. CpG DNA as a vaccine adjuvant.
Klinman DM
Expert Rev Vaccines; 2003 Apr; 2(2):305-15. PubMed ID: 12899580
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo.
Zhang L; Zhang M; Li J; Cao T; Tian X; Zhou F
Res Vet Sci; 2008 Dec; 85(3):495-502. PubMed ID: 18359498
[TBL] [Abstract][Full Text] [Related]
10. CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine.
Klinman DM; Xie H; Ivins BE
Ann N Y Acad Sci; 2006 Oct; 1082():137-50. PubMed ID: 17145935
[TBL] [Abstract][Full Text] [Related]
11. The potential of CpG oligodeoxynucleotides as mucosal adjuvants.
McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
Crit Rev Immunol; 2001; 21(1-3):103-20. PubMed ID: 11642598
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.
Vollmer J; Krieg AM
Adv Drug Deliv Rev; 2009 Mar; 61(3):195-204. PubMed ID: 19211030
[TBL] [Abstract][Full Text] [Related]
13. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
Weiner GJ
J Leukoc Biol; 2000 Oct; 68(4):455-63. PubMed ID: 11037965
[TBL] [Abstract][Full Text] [Related]
14. Cytosine-phosphate-guanine motifs fail to promote T-helper type 1-polarized responses in human neonatal mononuclear cells.
Prescott SL; Irwin S; Taylor A; Roper J; Dunstan J; Upham JW; Burgner D; Richmond P
Clin Exp Allergy; 2005 Mar; 35(3):358-66. PubMed ID: 15784116
[TBL] [Abstract][Full Text] [Related]
15. Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides.
Mutwiri GK; Nichani AK; Babiuk S; Babiuk LA
J Control Release; 2004 May; 97(1):1-17. PubMed ID: 15147800
[TBL] [Abstract][Full Text] [Related]
16. Co-administration of carcinoembryonic antigen and HIV TAT fusion protein with CpG-oligodeoxynucleotide induces potent antitumor immunity.
Woo SJ; Kim CH; Park MY; Kim HS; Sohn HJ; Park JS; Kim HJ; Oh ST; Kim TG
Cancer Sci; 2008 May; 99(5):1034-9. PubMed ID: 18294279
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvant.
Kodama S; Abe N; Hirano T; Suzuki M
Laryngoscope; 2006 Feb; 116(2):331-5. PubMed ID: 16467729
[TBL] [Abstract][Full Text] [Related]
18. CpG oligodeoxynucleotide synergizes innate defense regulator peptide for enhancing the systemic and mucosal immune responses to pseudorabies attenuated virus vaccine in piglets in vivo.
Cao D; Li H; Jiang Z; Cheng Q; Yang Z; Xu C; Cao G; Zhang L
Int Immunopharmacol; 2011 Jun; 11(6):748-54. PubMed ID: 21310256
[TBL] [Abstract][Full Text] [Related]
19. Enhancing vaccines with immune stimulatory CpG DNA.
Krieg AM; Davis HL
Curr Opin Mol Ther; 2001 Feb; 3(1):15-24. PubMed ID: 11249727
[TBL] [Abstract][Full Text] [Related]
20. Local therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out mice.
Matheu V; Treschow A; Teige I; Navikas V; Issazadeh-Navikas S
Respir Res; 2005 Mar; 6(1):25. PubMed ID: 15748290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
